{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:50:44Z","timestamp":1788846644903,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41443-020-0231-y","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T13:02:29Z","timestamp":1580130149000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term patient-reported outcomes in men with Peyronie\u2019s disease undergoing nonsurgical and nonintralesional injection management"],"prefix":"10.1038","volume":"33","author":[{"given":"Edward","family":"Capoccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Emmerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lankford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ofori-Marfoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"231_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/tau.2016.04.05","volume":"5","author":"S Al-Thakafi","year":"2016","unstructured":"Al-Thakafi S, Al-Hathal N. Peyronie\u2019s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up. Transl Androl Urol. 2016;5:280\u20139.","journal-title":"Transl Androl Urol"},{"key":"231_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.sxmr.2015.10.002","volume":"4","author":"AS Herati","year":"2016","unstructured":"Herati AS, Pastuszak AW. The genetic basis of peyronie disease: a review. Sex Med Rev. 2016;4:85\u201394.","journal-title":"Sex Med Rev"},{"key":"231_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","volume":"19","author":"M Arafa","year":"2007","unstructured":"Arafa M, Eid H, El-Badry A, Ezz-Eldine K, Shamloul R. The prevalence of Peyronie\u2019s disease in diabetic patients with erectile dysfunction. Int J Impot Res. 2007;19:213\u20137.","journal-title":"Int J Impot Res"},{"key":"231_CR4","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, et al. Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171:2350\u20133.","journal-title":"J Urol"},{"key":"231_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie\u2019s disease: results of a large survey. BJU Int. 2001;88:727\u201330.","journal-title":"BJU Int"},{"key":"231_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","volume":"7","author":"R Tal","year":"2010","unstructured":"Tal R, Heck M, Teloken P, Siegrist T, Nelson CJ, Mulhall JP. Peyronie\u2019s disease following radical prostatectomy: incidence and predictors. J Sex Med. 2010;7:1254\u201361.","journal-title":"J Sex Med"},{"key":"231_CR7","doi-asserted-by":"crossref","unstructured":"Tsambarlis P, Levine LA. Nonsurgical management of Peyronie's disease. Nat Rev Urol. 2019;16:172\u201386.","DOI":"10.1038\/s41585-018-0117-7"},{"key":"231_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.21037\/tau.2016.03.24","volume":"5","author":"B Barrett-Harlow","year":"2016","unstructured":"Barrett-Harlow B, Wang R. Oral therapy for Peyronie\u2019s disease, does it work? Transl Androl Urol. 2016;5:296\u2013302.","journal-title":"Transl Androl Urol"},{"key":"231_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, et al. Peyronie\u2019s disease: AUA guideline. J Urol. 2015;194:745\u201353.","journal-title":"J Urol"},{"key":"231_CR10","doi-asserted-by":"crossref","unstructured":"Moncada I, Krishnappa P, Romero J, et al. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study. BJU Int. 2019;123:694\u2013702.","DOI":"10.1111\/bju.14602"},{"key":"231_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jsm.12400","volume":"11","author":"JI Martinez-Salamanca","year":"2014","unstructured":"Martinez-Salamanca JI, Egui A, Moncada I, Minaya J, Ballesteros CM, Del Portillo L, et al. Acute phase Peyronie\u2019s disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. J Sex Med. 2014;11:506\u201315.","journal-title":"J Sex Med"},{"key":"231_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"231_CR13","doi-asserted-by":"crossref","unstructured":"Chung E. Penile reconstructive surgery in peyronie disease: challenges in restoring normal penis size, shape, and function. World J Mens Health. 2020;38:1\u20138.","DOI":"10.5534\/wjmh.170056"},{"key":"231_CR14","doi-asserted-by":"publisher","first-page":"S815","DOI":"10.21037\/tau.2017.03.83","volume":"6","author":"OA Raheem","year":"2017","unstructured":"Raheem OA, Hsieh TC. Penile prosthetic surgery for the management of Peyronie\u2019s disease. Transl Androl Urol. 2017;6:S815\u201321.","journal-title":"Transl Androl Urol"},{"key":"231_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1743-6109.2012.02999.x","volume":"10","author":"CJ Nelson","year":"2013","unstructured":"Nelson CJ, Mulhall JP. Psychological impact of Peyronie\u2019s disease: a review. J Sex Med. 2013;10:653\u201360.","journal-title":"J Sex Med"},{"key":"231_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.urology.2017.11.012","volume":"113","author":"M Ziegelmann","year":"2018","unstructured":"Ziegelmann M, Bole R, Avant R, Yang D, Montgomery B, Trost L. Conservatively managed Peyronie\u2019s disease-long-term survey results from patients undergoing nonsurgical and noninjection therapies. Urology. 2018;113:99\u2013104.","journal-title":"Urology"},{"key":"231_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0022-5347(17)61894-9","volume":"103","author":"JL Williams","year":"1970","unstructured":"Williams JL, Thomas GG. The natural history of Peyronie\u2019s disease. J Urol. 1970;103:75\u20136.","journal-title":"J Urol"},{"key":"231_CR18","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","volume":"144","author":"MK Gelbard","year":"1990","unstructured":"Gelbard MK, Dorey F, James K. The natural history of Peyronie\u2019s disease. J Urol. 1990;144:1376\u20139.","journal-title":"J Urol"},{"key":"231_CR19","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie\u2019s disease. J Urol. 2006;175:2115\u20138. discussion 2118.","journal-title":"J Urol"},{"key":"231_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.urology.2018.07.039","volume":"122","author":"NM Haney","year":"2018","unstructured":"Haney NM, Kohn TP, Nichols PE, Hellstrom W. The effect of adjunct mechanical traction on penile length in men undergoing primary treatment for Peyronie\u2019s disease: a systematic review and meta-analysis. Urology. 2018;122:110\u201315.","journal-title":"Urology"},{"key":"231_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1743-6109.2011.02519.x","volume":"9","author":"MR Abern","year":"2012","unstructured":"Abern MR, Larsen S, Levine LA. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie\u2019s disease. J Sex Med. 2012;9:288\u201395.","journal-title":"J Sex Med"},{"key":"231_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/0092623X.2016.1147511","volume":"43","author":"S Davis","year":"2017","unstructured":"Davis S, Ferrar S, Sadikaj G, Binik Y, Carrier S. Shame, catastrophizing, and negative partner responses are associated with lower sexual and relationship satisfaction and more negative affect in men with Peyronie\u2019s disease. J Sex Marital Ther. 2017;43:264\u201376.","journal-title":"J Sex Marital Ther"},{"key":"231_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","volume":"190","author":"WJ Hellstrom","year":"2013","unstructured":"Hellstrom WJ, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J. Bother and distress associated with Peyronie\u2019s disease: validation of the Peyronie\u2019s disease questionnaire. J Urol. 2013;190:627\u201334.","journal-title":"J Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-020-0231-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-020-0231-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-020-0231-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:07Z","timestamp":1684618267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-020-0231-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1038\/s41443-020-0231-y","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"25 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"LL is a speaker and consultant to Boston Scientific and Coloplast. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}